Dose Optimization for Stroke Evaluation (DOSE)
Optimizing the Dose of Rehabilitation After Stroke.
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A PHASE1 clinical study on Brain Ischemia and Cerebrovascular Disorders, this trial is completed. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
May 2017 — Jun 2018 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE1
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .